Bevonescein for Improved Intraoperative Nerve Visualization to Improve Voice Outcomes in Thyroidectomy Patients

NCT07631650 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Disorder
Head and Neck Cancer

Interventions

DRUG: Bevonescein (ALM 488) Infusion

Sponsor

Matthew Spector

Collaborators

[object Object]